Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04053309 · ClinicalTrials.gov registry record
Round Spermatid Injection Protocol
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04053309: Clinical Trial study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT04053309 is a clinical trial that was terminated before completion, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04053309 was terminated before completion, sponsored by Reproductive Medicine Associates of New Jersey.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
To evaluate embryology outcomes after application of a technique known as round spermatid injection (ROSI) into donor oocytes in a high-volume clinical infertility practice.
Primary Outcome
number of fertilized eggs progressing to the blastocyst stage of development which are euploid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-08-16 |
| Est. Completion | 2021-01-08 |
Why NCT04053309 stopped before completion
NCT04053309 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04053309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04053309 about?
NCT04053309 is a clinical study titled "Round Spermatid Injection Protocol". To evaluate embryology outcomes after application of a technique known as round spermatid injection (ROSI) into donor oocytes in a high-volume clinical infertility practice.
What is the current status of trial NCT04053309?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2019-08-16. Estimated completion is 2021-01-08.
Who is sponsoring clinical trial NCT04053309?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI